$39.08 +0.03 (0.08%) Sanofi Shs Sponsored American Deposit Receipt Repr 1/2 Sh - New York Stock Exchange, Inc.

Aug. 24, 2016 | 12:40 PM
Last Trade: 39.08
Trade Time: Aug 24 12:40 PM Eastern Daylight Time
Change: +0.03 (0.08%)
Prev Close: 39.05
Open: 39.08
Bid: 39.08
Ask: 39.08
  1. Regeneron Stock Dips As Earnings Beat And Revenue Lags

    Investors Business Daily | Aug. 4, 2016 | 10:44AM EST
  2. Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch Names

    Investors Business Daily | Aug. 1, 2016 | 12:20PM EST
  3. AbbVie, Merck Beat Earnings Estimates, But Sanofi Lags

    Investors Business Daily | Jul. 29, 2016 | 10:46AM EST
  4. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 10:44AM EST
  5. Regeneron Q4 Earnings Miss Estimates Amid Slow Praluent Launch

    IBD | Feb. 9, 2016 | 11:28AM EST
  6. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD | Jan. 15, 2016 | 15:00PM EST
  7. Drug Stocks Mixed On Guidance Updates

    IBD | Jan. 12, 2016 | 18:45PM EST
  8. Sanofi, Innate Pharma Collaborate on New Bispecific NK Cell Engagers in Immuno-Oncology

    Benzinga | Jan. 11, 2016 | 05:25AM EST
  9. Sanofi, Warp Drive Bio to Collaborate on Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms

    Benzinga | Jan. 11, 2016 | 04:20AM EST
  10. US Stock Futures Surge After Jobs Data

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  11. U.S. Stock Futures Surge After Jobs Data; El-Erian To Discuss Economic Situation

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  12. Regeneron, Sanofi Announce Sarilumab Biologics License Application Accepted for Review FDA

    Benzinga | Jan. 8, 2016 | 04:01AM EST
  13. Gilead Leads 3 Drug Stocks With Top Fundamentals

    IBD | Jan. 7, 2016 | 08:02AM EST
  14. MannKind Is Plummeting

    Benzinga | Jan. 5, 2016 | 09:19AM EST
  15. Why MannKind Could Be a Value Trap

    GuruFocus | Jan. 4, 2016 | 14:15PM EST
Trading Center